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Background: The recommendations in clinical guidelines for duration of therapy for alcohol use disorder (AUD)
are based on consensus decisions. In reality,we do not know the optimal duration of an alcohol treatment course.
Methods: A systematic review and meta-regression of randomized controlled trials of psychosocial treatment in
alcohol outpatient treatment centers. The population consisted of adults suffering fromAUD, treated in an outpa-
tient facility with at least two sessions of therapy. Meta-regression analysis was performed with treatment out-
come as a function of duration of therapy across studies. Treatment outcome was deﬁned as long-term alcohol
use measured in percentage of days abstinent (PDA), percentage of heavy days drinking (PHD), and/or propor-
tion of participants abstinent (ABS).
Results: 48 studies encompassing 8984 participants. Mean planned duration of therapy: 18 (8–82) weeks and 14
(2–36) sessions. Mean actual attended sessions: 9 (1–26). Mean follow-up time: 43 (8–104) weeks with a mean
of 6 (2–18) research assessments. Neither planned weeks, duration of sessions, frequency of sessions per week,
nor actual attended sessions were associated with long-term alcohol use outcomes. However, frequency of re-
search assessments was positively associated with PDA and PHD.
Conclusion:No associations between long-term alcohol use outcomes and planned or actual attended duration of
psychosocial treatment in outpatient care. Research assessments and, accordingly, the research project in itself
may inﬂuence outcome in studies of psychosocial treatment for alcohol use disorder.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Many different psychosocial treatments are offered to patients with
alcohol use disorder (AUD). In large part, they have been found equally
effective (Martin & Rehm, 2012). While some therapies are conducted
over a fewweeks, others may last for years. But what is the optimal du-
ration of therapy?
The question about duration of therapy is not new. Dose-response
research in psychotherapy in general has sought to answer the ques-
tion: “Howmuch therapy is enough?” Two major models of how to ex-
plain and study the associations between duration and outcome are the
“dose-effect” model and the “good-enough level” model. The dose-
effect model is based on a medical understanding of dose and assumes
a positive association between outcome anddose in the form of sessions
demonstrating a negatively accelerating curve: that is, patients improve
as the number of sessions increases, but at higher doses the beneﬁt of
additional sessions decreases (Kopta, 2003). Based on the dose-effect
model, reviews of the duration of psychotherapy estimate that after
13 to 18 sessions, 50% of the patients achieve a good clinical outcome
(Hansen, Lambert, & Forman, 2002; Howard, Kopta, Krause, &
Orlinsky, 1986). The good-enough level model is based on the belief
that patients respond to treatment at different rates and that outcome
trajectories are steeper for patients attending fewer sessions
(Barkham et al., 2006). This indicates that longer treatment duration
might be associated with less rapid rates of change at the individual
level (Barkham et al., 2006).
Reviews of duration of therapy for substance use disorder have ap-
plied the dose-effect model, but have focused on planned duration of
continuing care. Continuing care is deﬁned as treatment after intensive
Journal of Substance Abuse Treatment 84 (2018) 57–67
Abbreviations: AUD, alcohol use disorder; ABS, proportion of participants abstinent;
CBT, cognitive behavioral therapy; DDD, drinks per drinking day; PDA, percentage of
days abstinent; PHD, percentage of heavy days drinking.
☆ Conﬂicts of interest: None.
⁎ Corresponding author.
E-mail address: lkramer@health.sdu.dk (L. Kramer Schmidt).
http://dx.doi.org/10.1016/j.jsat.2017.11.002
0740-5472/© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
Journal of Substance Abuse Treatment
in- or outpatient care (Lenaerts et al., 2014). Small to no advantages for
longer planned durations of continuing care have been found (Blodgett,
Maisel, Fuh, Wilbourne, & Finney, 2014; Lenaerts et al., 2014; McKay,
2005, 2009). Moreover, motivational enhancement therapy, which
often includes four planned sessions of therapy, has been proven as ef-
fective a treatment as cognitive behavioral therapies with longer dura-
tions (Martin & Rehm, 2012; Smedslund et al., 2011).
In the treatment of substance use disorder, duration and intensity of
treatment have been studied in non-comparable ways andwith diverg-
ing ﬁndings. Some have found inverse associations between longer du-
ration of treatment and drug use outcomes. Magill and Ray (2009)
analyzed the effect of cognitive behavioral therapy for substance use
disorder in 53 studies and found effect-size diminished after twenty ses-
sions of therapy. Another study analyzed 34 outpatient psychosocial in-
tervention studies for substance use disorders (excluding alcohol
dependence), and found that the number of treatment weeks was neg-
atively correlated with substance use outcomes (Dutra et al., 2008). Fi-
nally, a study of planned duration of inpatient drug abuse treatment
found better effects (in 628 participants) after six months (comprising
42 sessions) of treatment than in either three or twelvemonths of treat-
ment (McCusker et al., 1997). In contrast, a recent Cochrane review
(Gates, Sabioni, Copeland, Le Foll, & Gowing, 2016) of 23 psychosocial
intervention studies for cannabis use disorder found positive associa-
tions between more than four sessions or four weeks of treatment and
an effect on use of cannabis, and a non-randomized study by Moos
and Moos (2003) encompassing 473 ﬁrst time treatment seekers with
AUD indicated not b27 weeks of in-or outpatient treatment to be
effective at one year follow-up (Moos & Moos, 2003). Moreover, there
are expert recommendations for treating AUD as a chronic disease,
with a continuum of care of possibly longer duration (McKay &
Hiller-Sturmhofel, 2011; Willenbring, 2013) or a stepped-care model
(Haber, Lintzeris, Proude, & Lopatko, 2009). Regarding intensity or fre-
quency of treatment, another Cochrane review (Lancaster & Stead,
2017) of behavioral interventions for smoking cessation indicated
higher intensity treatment may be better than lower, but in general, in-
tensity of treatment was not associated with use of drugs in the above-
mentioned studies (Dutra et al., 2008; Moos & Moos, 2003), except for
one which found lower intensity to be better (McCusker et al., 1997).
Reviews of duration of therapy in general and for substance use dis-
orders in particular have assumed treatment uniformity and pooled dif-
ferent treatments. Since variation in treatment effect sizes is low, and
other possible causes of the efﬁcacy of treatment than the speciﬁc treat-
mentmethods are considered (Imel,Wampold,Miller, & Fleming, 2008;
Miller & Moyers, 2015), the assumption of treatment uniformity will
also be applied in this study.
Given the gap in the literature concerning the appropriate duration
of therapy for AUD in alcohol outpatient care, the recommendations
for the planned duration of therapy for AUD are based on consensus de-
cisions (Group, 2008; Haber et al., 2009; Health, 2011; Kleber &
Association, 2006). If the effect of duration of therapy is unknown,
risks are that patients will receive either too little or too much therapy,
with burdensome consequences for both themselves and society
(Cuijpers, Huibers, Ebert, Koole, & Andersson, 2013).
Relatedly, how much therapy is actually received? Reviews of
therapy for AUD are primarily based on planned durations rather than
actually attended weeks or sessions. Moreover, duration of therapy
can be interpreted in different ways and in this study we want to in-
clude both the planned and actual duration in weeks, duration of ses-
sions, and frequency of sessions per week. Another concern of
psychotherapeutic research for AUD is the effect of research assess-
ments as studied by Clifford and Maisto (2000). Since there is a risk of
research assessments having a therapeutic effect, the duration and fre-
quency of these will also be taken into account (Clifford, Maisto, &
Davis, 2007).
The treatment duration of outpatient care for AUD in general has to
our knowledge not been investigated, and a search in the databases for
randomized controlled studies of different lengths of the same treat-
ment for AUD threw up only one study (Kamara & VanDer Hyde, 1997).
It is, therefore, an open question whether there are associations be-
tween alcohol use outcomes and duration of therapy for AUD as in psy-
chotherapy in general. Knowledge in this area could optimize treatment
in alcohol outpatient centers.
To test whether there are positive associations between outcome
and duration of treatment of AUD – applying the dose-effect model
and assuming treatment uniformity – the research questions of this
study are:
- Are there positive associations between duration of treatment and
long-term alcohol use outcomes in a population randomized to dif-
ferent kinds of outpatient psychosocial therapy for AUD? Duration
of treatment deﬁned as planned and attendedweeks, number of ses-
sions, and frequency of sessions per week.
- Howdoes the duration of the research assessments of the studies in-
cluded affect the long-term alcohol use outcomes? Duration of the
research assessments deﬁned as the number of research assess-
ments, duration of follow-up in weeks, and the frequency of the re-
search assessments over this period.
2. Methods
2.1. Information sources
We searched PubMed and Psych info, covering the years from 1966
to 2016, using the search terms: "Alcoholism"[Mesh], therapy*, treat-
ment*, intervention*, train*, counsel*, course*, program*, coach*, ses-
sion*, consultat*, guid*, mentor*, interview*, period*, month*, week*,
year*, length, sequence*, time, duration*, schedul*, short-term, long-
term, outpatient*, out-patient*, ambulatory, ambulant. Filters used
were randomized controlled trials and only articles in English were
reviewed.
A search through references of the background literature and of in-
cluded articles was also reviewed for potential studies.
The searches were performed in November 2016.
2.2. Eligibility criteria
Using the PRISMA guidelines for systematic reviews (Moher,
Liberati, Tetzlaff, & Altman, 2010), the following study characteristics
were included (PICO):
Study population: A population randomized at the start of different
psychosocial treatments at an outpatient facility for AUD by DSM-III or
IV (APA, 1980, 1994). If DSMcriteriawere not described in the inclusion,
the characteristics of the study population at baseline were checked to
see if they were likely to fulﬁll criteria for AUD. If the populations
were described as alcoholics, alcohol abusers, addicts, alcohol depen-
dent, or had a MAST (Michigan Alcohol Screening Test) (Selzer, 1971)
score above ﬁve, they were included. Comorbidity was accepted, but
the primary aim of the study was to investigate AUD ﬁrst and foremost.
Use ofmedication for treatingAUDwas accepted. Furthermore, the pop-
ulation had to be adults (N17 years) and to have received nomore than
one month of inpatient treatment prior to the intervention studied.
Intervention: Any psychosocial intervention performed in outpa-
tient alcohol care services with personal contact (face-to-face, tele-
phone, computer), group or individual treatment, and involving a
minimum of two sessions. If the control condition in the study fulﬁlled
these criteria, it was also registered as an intervention.
Comparison: The treatments were not compared relative to one an-
other within the same study. Instead, data on treatment duration from
each intervention were used in the meta-analysis and compared across
studies and treatment methods.
Outcomewas themost frequently usedmeasures of long-term alco-
hol use: percent days abstinent (PDA), percent heavy days drinking
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(PHD), drinks per drinking day (DDD), and proportion of participants
abstinent (ABS).
2.3. Study selection
The searches were screened by the ﬁrst author, using the eligibility
criteria mentioned above. If exclusion was not possible by title or ab-
stract, the articles were downloaded as full-texts. These were read by
three of the authors (Schmidt L.K., Nielsen A.S., Andersen K.) and inclu-
sion was decided based on consensus.
2.4. Data collection
Because we studied duration of treatments across studies and treat-
ment types, i.e. assuming treatment uniformity, both the control condi-
tion and the intervention of the studies were in this case considered to
be interventions. The following data were registered for each interven-
tion in the studies: number of participants, therapeutic method, wheth-
er there was a pharmacological intervention together with the
psychosocial intervention, number of weeks planned, mean number of
actually attended weeks, number of planned sessions, mean of actually
attended sessions, duration of the research study, number of research
assessments, baseline and follow-up data of outcome (PDA, PHD, DDD
and/or ABS), and whether outcome was reported as intention to treat
or as completers. Recent studies emphasize outcome in psychosocial
functioning (Wilson, Bravo, Pearson, & Witkiewitz, 2016), therefore,
sub-analysis of this outcome was considered and data on psychosocial
functioning at follow-up was registered. Finally, demographic and de-
scriptive data were registered.
2.5. Data items
Treatment duration: The planned and actually attended weeks and
sessions as described for each individual treatment arm in the study,
starting with treatment in the outpatient setting. Moreover, the fre-
quency of sessions per week was calculated. In a few cases, the studies
reported attrition rate in percentage terms, hence, the actually attended
weeks/sessions were calculated. Since half of the studies reported actu-
ally attended sessions, we contacted the authors of the studies not
reporting this informationwith the result that nine studies subsequent-
ly provided the information. Actual attendedweekswere reported even
more seldom and we concluded that it would not be feasible to collect
enough information on this variable.
Therapeutic method: In order to check the assumption of treatment
uniformity, the interventions were classiﬁed according to methods
used. If cognitive and behavioral strategieswere described as a substan-
tial part of the treatment, the interventionwas classiﬁed as cognitive be-
havioral therapy (CBT). Treatment was classiﬁed according to therapy
applied, if possible. If the intervention was described as a standard
care intervention without further information regarding content, it
was listed as treatment as usual.
Follow-up time: The number of weeks from baseline to the follow-
upwhere the primary outcomewasmeasured. If outcomes from several
follow-upswere listed and nonewere speciﬁed as theprimary outcome,
the follow-up after 26 weeks was chosen. This was in order to optimize
homogeneity between studies and, rather than measuring the outcome
immediately after treatment, long-term outcomes were chosen when-
ever possible. Moreover, a study by Magill and Ray (2009) reported
that 26 weeks is one of the more stable outcome points in comparable
ﬁelds.
Research assessments: Interviews and follow-ups of the participants
at baseline, throughout, and following treatment. Deﬁned as a meeting
with research staff (either face-to-face or by phone) where data of alco-
hol usewas registered, butwithout engagement in treatment. The num-
ber of research assessments extended up to and including the one
where the primary outcome was registered.
Alcohol use outcomes were PDA, DDD, PHD and/or ABS. If data were
presented in a way that made it possible to obtain the outcome through
calculations, this was done. Because outcomes on psychosocial func-
tioning differed widely in the studies, only the source of the data was
registered.
Intention to treat: If the statistics described an intention-to-treat
analysis or outcome, this was reported as based on the number of par-
ticipants at baseline. Otherwise the data were registered in the analysis
as based on completers.
2.6. Statistics
Meta-regression analysis was used to describe associations between
outcome and the following explanatory variables: plannedweeks, actu-
ally attended weeks, planned sessions, actually attended sessions, fre-
quency of sessions per week, follow-up time, number of research
assessments during the study, and frequency of research assessments
per month (28 days) of the follow-up time. Intercorrelations between
explanatory variables were computed and we used the metareg pack-
age for Stata (Harbord & Higgins, 2008). Standard error estimates
were calculated for each group based on number of patients included
and using the normal approximation method for proportions.
In order to control for the diversity of treatments and studies, we ap-
plied several binary control variables: 1) whether the intervention was
classiﬁedasCBT, 2) analysis basedon intention to treat, 3)pharmacolog-
ical intervention as part of the psychosocial intervention, 4) abuse of
other drugs in the population, and 5) severe psychiatric comorbidity
in the population. Finally, adjustments on other demographic data as
described in data collection were considered.
2.7. Publication bias
Since we included the control groups of the studies as interventions
and compared the interventions across studies, we were unable to re-
port evidence of publication bias. The possible effects we wanted to an-
alyze were in relation to duration and intensity across the studies.
Because outcomes from both control groups and intervention groups
are considered in our study, the analytical approach does not apply to
how the biases in publications are usually reported, with funnel plots
of effect sizes in relation to sample size or error estimates.
3. Results
3.1. Search results
Search results are displayed in Fig. 1.
3.2. Characteristics of included studies
Tables 1 and 2 present the characteristics of the 8984 participants
and the 48 studies/133 interventions included. Themajority of the stud-
ies originated in the USA and otherWestern countries. Years of publica-
tion ranged between 1974 and 2016 with 32 of the studies published
after 1999.
Thirty-three studies included participants who fulﬁlled criteria for
alcohol use disorders by DSM. The remainder had a baseline description
of a population likely to fulﬁll criteria for alcohol use disorder. Most
studies (n= 31) recruited through contact in an alcohol outpatient set-
ting; of these, 11 also recruited through advertisement. The remainder
was recruited through amix of inpatient settings, veteran clinics, adver-
tisement only, and primary care. Information on previous treatment at-
tempts, pharmacological treatment and other scores of severity of
alcohol abuse was not reported consistently.
Of the 133 interventions, 53% were CBT, 10% were twelve-step facil-
itation, 10% were motivational interviewing, 7% were treatment as
usual, while the remaining interventions included psychodynamic
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therapy, educational sessions, relaxation training, short telephone
calls with monitoring of alcohol use with or without feedback, non-
directive reﬂective listening, and conjoint therapy.
Three (“Effectiveness of treatment for alcohol problems: ﬁndings of the
randomised UK alcohol treatment trial (UKATT)”, 2005; Lam et al., 2009;
O'Farrell et al., 1992) had psychosocial functioning as a primary out-
come and 33 reported it as a secondary outcome, but the reporting
was very diverse and collected by non-comparable methods.
3.3. Duration and treatment effect
Actually attended weeks could not be analyzed as a predictor due
to too few observations, given that weekly attendance was only report-
ed in ﬁve studies. Attended sessions were reported in 33 studies, so
there were enough observations to perform sub-analysis on this
predictor.
The outcome DDD had only 38 observations and these were report-
ed differently; thus, the number of observations where standard errors
could be calculated was too low and this outcome had to be omitted
from further analysis. Since none of the studies reported only DDD, no
studies were excluded because of this.
The results of the meta-regression are displayed in Table 3. Neither
planned duration of treatment nor frequency of planned treatment
had signiﬁcant associations with any of the outcome measures. Two
sub-analyses were performed: 1) a meta-regression with actually
attended sessions instead of planned sessions, and 2) a meta-
regression with the attrition rate instead of sessions. Attrition rate was
deﬁned as the rate of actual attended sessions per planned sessions.
No signiﬁcant associations were found in the two sub-analyses (not
shown in Table 3). Frequency of research assessments was positively
and signiﬁcantly associated with the two outcome measures with the
highest number of observations: PDA and PHD. The coefﬁcient indicates
that increasing the frequency of research assessments with one more
per month will increase PDA by between 3% and 22% (p b 0.05) and de-
crease PHD by between 6% and 38% (p b 0.01).
Additionally, an overview of the binary correlations between all var-
iables is presented in Table 4.
3.4. Control variables
The binary control variables are also displayed in Table 3. The
outcome measure with the most observations - percent days
abstinent (PDA) and percent heavy days of drinking (PHD) was not
signiﬁcantly associated with any of the binary control variables.
Medication in the study was signiﬁcantly associated with a lower pro-
portion of participants abstinent, as based on the 14 interventions that
included medication as part of the intervention, and reporting outcome
by the proportion of participants abstinent. Except for the weighted
analysis by number of participants, the demographic variables were
left out of the analysis to maintain a reasonably low number of model
parameters.
4. Discussion
4.1. Summary of results
We have systematically reviewed and analyzed 48 studies of psy-
chosocial interventions for alcohol use disorders (AUD) in outpatient
care. The main result of the meta-regression was that planned weeks,
planned sessions, actual attended sessions, attrition rate, as well as fre-
quency of planned sessions per week, were not associated with long-
term alcohol use outcomes. In addition, signiﬁcant and positive associa-
tions were found between frequency of research assessments and long-
term alcohol use outcomes: percent days abstinent and percent heavy
days of drinking.
Fig. 1. Flow diagram from the search in the systematic review of the duration of psychosocial treatments for alcohol use disorders. Search performed in November 2016.
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Table 1
Descriptive data from the 48 included studies in the systematic review andmeta-analysis of duration of treatment for alcohol use disorders. Including diagnosis in population, number of
participants, treatment duration and type of intervention.
Author (ref.) YOPa Diagnostic criteria
for AUDb
Outcome
measuresc
Weeks
of study
RASd NOPe Method of
interventionf
Planned Weeks
of treatment
Actual
Weeks
Planned
Sessions
Actual
sessions
Annis and Peachey (1992) 1992 DSM-III PDA, PHD, DDD 26 2 23 1 16 8
Anton et al. (2005) 2005 DSM-IV PDA, DDD 12 4 39 2 12 4 3
41 2 12 4 3
39 1 12 12 9
41 1 12 12 9
Azrin, Sisson, Meyers, and Godley
(1982) 1982
Alcoholics PDA, DDD 26 7 14 4 5 5 4,9
15 5 5 5 4,5
14 1 5 5 6,4
Balldin et al. (2003) 2003 DSM-IV PDA, PHD, DDD 24 3 30 1 24 9
32 4 24 9
25 1 24 9
31 4 24 9
Bowers and al-Redha (1990) 1990 Alcohol problems ABS 26 3 8 1 9 8,5
8 5 7,4 7,4
Brown, Saunders, Bobula, Mundt, and
Koch (2007) 2007
DSM-IV ABS, PHD 12 2 199 2 12 6
246 2 12 6
Burtscheidt, Wolwer, Schwarz,
Strauss, and Gaebel (2002) 2002
DSM-III 26 2 31 1 26 26 13.9
32 1 26 26 13.9
40 4 26 26
Chapman and Huygens (1988) 1988 Alcoholics ABS, DDD 26 2 23 5 6 12
Anton et al. (2006) 2006 DSM-IV PDA 68 5 153 3 16 9 9
152 3 16 9 9
154 3 16 9 9
148 3 16 9 9
156 1 16 29 19
151 1 16 29 19
155 1 16 29 19
157 1 16 29 19
157 1 16 20 10
Connors, Walitzer, and Dermen
(2002) 2002
DSM-III PDA, PHD 26 3 126 1 12 24 9.8
Davis, Campbell, Tax, and Lieber
(2002) 2002
Alc.dep. PDA, ABS, DDD 26 7 40 5 26 26
49 4 26
De Wildt et al. (2002) 2002 DSM-IV ABS, DDD 28 7 86 2 4 3 2,84
78 1 8 7 5,32
Dieperink et al. (2014) 2014 DSM-IV PDA, ABS, PHD 26 3 70 2 12 4 3.2
68 5 12 4 3.2
Fals-Stewart, Birchler, and Kelley
(2006) 2006
DSM-IV PDA 46 4 46 1 20 32 23,94
46 1 20 32 25,6
46 1 20 32 23,6
Fals-Stewart, Klostermann, Yates,
O'Farrell, and Birchler (2005) 2005
DSM-IV PHD 38 4 25 1 12 18 15
25 1 12 24 19,2
25 3 12 18 15,7
25 3 12 18 14,4
Hammarberg, Wennberg, Beck, and
Franck (2004) 2004
DSM-IV PDA, PHD 24 4 32 5 24 4 2.8
29 5 24 19 15.5
Heather et al. (2000) 2000 Alcohol dependence PDA, ABS, DDD 42 3 48 1 16 16 7,67
43 1 16 16 6,56
Hedberg and Campbell (1974) 1974 Alcoholism ABS 26 2 15 1 26 21
15 1 25 21
12 1 25 21
15 1 25 21
Kiluk et al. (2016) 2016 DSM-IV PDA, PHD 34 11 22 1 8 8 4.3
22 1 8 8 5.1
24 5 8 8 5
Lam, Fals-Stewart, and Kelley (2009)
2009
DSM-IV PDA 26 3 10 1 12 24
10 1 12 24
10 1 12 24
Litt, Kadden, Kabela-Cormier, and
Petry (2007) 2007
DSM-IV PDA, ABS 64 7 63 3 12 12 8.3
59 1 12 12 8.6
64 5 12 12 9.2
Litt, Kadden, and Kabela-Cormier
(2009) 2009
DSM-IV PDA, ABS, PHD 16 2 57 1 12 12 7.5
53 1 12 12 8.3
Longabaugh, Wirtz, Beattie, Noel, and
Stout (1995) 1995
DSM-III PDA 78 18 58 1 52 20 12
50 1 52 20 10,23
57 1 52 20 10,04
Maisto, Sobell, Sobell, and Sanders
(1985) 1985
Alc.dep. PDA, PHD 78 18 13 5 20,5 16,3
12 5 29,6 21,6
11 5 20,5 16,3
12 5 29,6 21,6
Marques and Formigoni (2001) 2001 DSM-III PDA, PHD 68 2 77 1 34 17 9
78 1 34 17 9
(continued on next page)
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Table 1 (continued)
Author (ref.) YOPa Diagnostic criteria
for AUDb
Outcome
measuresc
Weeks
of study
RASd NOPe Method of
interventionf
Planned Weeks
of treatment
Actual
Weeks
Planned
Sessions
Actual
sessions
McCrady, Epstein, and Hirsch (1999)
1999
DSM-III PDA, ABS, PHD 48 8 30 1 15 22 15 10,4
31 1 64 25 19 11,1
29 1 15 21 15 10,6
McCrady et al. (1986) 1986 MAST N 5 PDA, ABS, PHD 40 9 13 1 15 16,7 15 13,9
11 1 15 16,7 15 13,9
18 1 15 16,7 15 13,9
McKay, Lynch, Shepard, and Pettinati
(2005) 2005
DSM-IV PDA, ABS 104 7 102 5 16 10,94
135 1 16 14,24
122 3 16 14,36
McKay et al. (2010) 2010 Alc.dep. PDA, ABS, PHD 78 7 86 4 26
83 5 82 36 12,5
83 5 82 36 10,1
Moraes, Mendes de Campos, Figlie,
Ferraz, and Laranjeira (2010) 2010
DSM-IV PDA, ABS, PHD 10 3 58 1 10 20
62 1 10 24
O'Farrell, Cutter, Choquette, Floyd,
and Bayog (1992) 1992
Alcoholics PDA, ABS, PHD 36 4 10 1 10 10
12 5 10 10
12 4 10 10
O'Malley et al. (1992) 1992 DSM-III PDA, ABS, DDD 12 4 29 1 12 9,8 12 9,4
23 5 12 9,8 12 9,4
25 1 12 9,8 12 9,4
27 5 12 9,8 12 9,4
O'Malley et al. (2003) 2003 DSM-III PDA, ABS, DDD 10 8 93 5 10 8,4 8 6,9
97 1 10 8,1 10 7,8
David W. Oslin et al. (2008) 2008 DSM-IV PDA, ABS, PHD, DDD 24 10 79 2 24 18 12,15
80 1 24 18 12,15
D. W. Oslin et al. (2014) 2014 DSM-IV PHD 26 3 78 3 26 3,79
85 2 26 10,25
Petry, Martin, Cooney, and Kranzler
(2000) 2000
DSM-IV ABS 8 11 19 1 8
23 3 8
Powell, Penick, Read, and Ludwig
(1985) 1985
DSM-III ABS 52 15 43 5 52
Project MATCH (Matching Alcoholism
Treatments to Client Heterogeneity:
Project MATCH posttreatment
drinking outcomes, 1997) 1997
DSM-III PDA, ABS, DDD 64 6 309 2 12 8,4 4 3.3
244 2 12 8,4 4 3.1
290 1 12 9,3 12 8.3
254 1 12 9,3 12 8.0
324 3 12 8,3 12 7.5
235 3 12 8,3 12 7.3
Sandahl, Herlitz, Ahlin, and Rönnberg
(1998) 1998
DSM-III PDA, ABS, PHD, DDD 80 3 24 1 15 15 9,5
25 5 15 15 8,9
Sanchez-Craig, Leigh, Spivak, and Lei
(1989) 1989
Problem drinkers PHD 58 4 11 1 6 3
11 1 6 3
10 1 6 6
6 1 6 3
14 1 6 3
9 1 6 6
Sellman, Sullivan, Dore, Adamson,
and MacEwan (2001) 2001
DSM-IV ABS 32 2 42 2 6 5 4.4
40 5 6 5 4.0
40 5 6 1 1.0
Saitz et al. (2013) 2013 Alc. dep. PHD, ABS 52 4 199 1 52 6
Stasiewicz et al. (2013) 2013 DSM-IV PDA, PHD, DDD 26 4 25 1 12 12 9,7
24 1 12 12 8,8
UKATT (“Effectiveness of treatment for
alcohol problems: ﬁndings of the
randomised UK alcohol treatment
trial (UKATT)”, 2005) 2005
Probl. drinkers PDA, DDD 52 3 422 2 10 3 1.9
320 1 12 8 3.4
Walitzer, Dermen, and Barrick (2009)
2009
Alcoholics PDA, PHD 52 5 51 3 12 12 6,9
51 2 12 12 6,9
50 4 12 12 6,9
Walitzer, Deffenbacher, and Shyhalla
(2015) 2015
DSM-IV PDA, DDD 4 36 1 12 6.4
40 3 12 6.4
Wetzel et al. (2004) 2004 DSM-IV PDA, ABS 52 3 53 1 12 24
50 5 12 24
50 1 12 24
47 5 12 24
Zweben, Pearlman, and Li (1988)
1988
MAST N 5 PDA, PHD 26 4 70 5 8 8
a YOP: year of publication.
b DSM: diagnostic and statistical manual. MAST: Michigan alcohol screening test.
c PDA: percentage of days abstinent. PHD: Percentage of heavy days drinking (Heavy drinking was deﬁned as 4 or more drinks per day for women and 5 or more drinks per
day for men in most of the studies. A few had a deﬁnition in oz. (N3 oz.) or grams (N68–80 g.) of alcohol and one reported it as a day where the participant felt intoxicated). ABS:
Share of participants abstinent (deﬁnition varies between one month abstinent and up to one year either abstinent or with few light drinking days). DDD: Drinks per drinking
day.
d RAS: research assessments.
e NOP: number of participants.
f Method of intervention: 1. Cognitive behavioral therapy, 2. Motivational interviewing, 3. Twelve Step Facilitation, 4. Treatment as usual, 5. Others (see text).
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4.2. One size does not ﬁt all
Overall, ourﬁndings are in linewith earlier reviews of planned dura-
tion and effect of treatment of substance use disorders (Blodgett et al.,
2014; Lenaerts et al., 2014; McKay, 2005, 2009).
One explanation of the lack of signiﬁcantﬁndingsmay be thehetero-
geneity of people suffering from AUD. Such heterogeneity coheres with
the good-enough level model, whereby people recover and their symp-
toms diminish at different rates (Barkham et al., 2006). This would sug-
gest that the dose-effect model is ill-ﬁtted for the analysis of the
effectiveness of duration of treatment among individuals with AUD.
Comparisons of the two models within psychotherapy in general indi-
cate that the dose-effect model ﬁts well at the beginning of therapy
(Baldwin, Berkeljon, Atkins, Olsen, & Nielsen, 2009; Delgadillo et al.,
2014), but that the good-enough level model is a better ﬁt with longer
treatment durations beyond six (Delgadillo et al., 2014) to eight
(Baldwin et al., 2009) sessions. On the other hand, these trajectories of
change seem interchangeable and more diverse than the models may
be able to grasp (Owen et al., 2015). Furthermore, it is likely that pa-
tients are inﬂuenced by information about the plannedduration of ther-
apy and may partly adjust their trajectory of change accordingly. A
constraint on research into the good-enough level model is that it
Table 2
Demographics and mean values of included studies in the meta-analysis of the duration of outpatient psychosocial treatments for AUD.
Mean Range SD Reported in % of
interventions:
Participants 70.7 6–422 100
Age (years) 42.1 32–57 98
Male (%) 75.9 0–100 93
Education time (years) 12.7 10–15 50
Married or cohabiting (%) 54.6 9–100 81
Employed (%) 62.4 13–93 57
Years of alcohol abuse 12.0 5–25 30
AUD by DSM-III or -IV 69
Baseline description of alcohol use disorder 31
Excluded participants with other drug abuse except from marihuana and nicotine 58
Included participants with other drug abuse except from marihuana and nicotine 23
Excluded severe psychiatric comorbidity 81
Included severe psychiatric comorbidity 6
Pharmacological intervention besides the psychosocial intervention 23
Recruited in an outpatient setting 65
Weeks of planned treatment 17.6 8–82 13.4 96
Weeks of actually attended treatment 12.9 8–25 10
Sessions of planned treatment 14.3 2–36 8.2 90
Sessions of actually attended treatment 9.5 1–26 5.0 68
Frequency of planned sessions per week 1.0 0.5 46
Duration of the research study (weeks) 42.7 8–104 23.1 98
Number of research assessments 5.5 2–18 3.8 100
Frequency of research assessments per 28 days 0.7 0.8 98
Outcome in percent days abstinent 73.2 33–97 14.0 73
Outcome in proportion of participants abstinent (%) 31.9 0–72 16.9 52
Outcome in percent heavy days of drinking 15.6 1–39 9.2 50
Studies reporting outcome in drinks per drinking day 33
Studies reporting outcome as intention to treat 48
Table 3
Meta-regression of the duration of psychosocial treatments for alcohol use disorder in outpatient care.
PDA PHD ABS
Coef. 95% CI Coef. 95% CI Coef. 95% CI
Explanatory variables
Planned sessions of treatment 0.01 −0.01,0.02 0.00 −0.01,0.02 0.00 −0.01,0.02
Planned weeks of treatment 0.00 −0.01,0.01 −0.00 −0.01,0.00 0.01 −0.00,0.01
Planned frequency of sessions per week −0.05 −0.28,0.18 −0.07 −0.21,0.07 0.10 −0.09,0.29
Follow-up time in weeks 0.00 −0.00,0.00 −0.00 −0.01,0.00 0.00 −0.00,0.00
Frequency of research assessments per month 0.12⁎ 0.03,0.22 −0.22⁎⁎ −0.38,-0.06 0.10 −0.00,0.20
Research assessments in study −0.00 −0.02,0.01 0.01 −0.01,0.02 0.01 −0.02,0.03
Baseline PDA 0.26 −0.16,0.67
Baseline PHD 0.06 −0.30,0.42
Binary control variables
Medication in study −0.04 −0.12,0.04 0.05 −0.04,0.13 −0.16⁎ −0.30,-0.01
Major psychiatric disorder included 0.08 −0.13,0.30 0.07 −0.11,0.25 0.27 −0.07,0.60
Missing information of major psychiatric disorder in study 0.11 −0.06,0.27 −0.03 −0.13,0.07 0.16 −0.12,0.44
Abuse of other drugs included −0.06 −0.23,0.11 −0.01 −0.11,0.09 −0.15 −0.38,0.08
Missing information of other drugs −0.10 −0.22,0.02 −0.01 −0.10,0.09 −0.00 −0.19,0.18
Completers or not (ref. = ITT) 0.06 −0.02,0.13 −0.06 −0.12,0.00 −0.04 −0.17,0.09
CBT or not (ref. = not CBT) 0.00 −0.06,0.07 −0.01 −0.06,0.04 −0.04 −0.12,0.05
No. of observations 93 52 49
Weighted by number of participants in the interventions/observations. PDA: percentage of days abstinent, PHD: percentage of days heavy drinking, ABS: share of participants abstinent.
CBT: cognitive behavioral therapies.
⁎ p b 0.05.
⁎⁎ p = b0.01.
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requires reporting of outcome at the individual level: session to session,
or at a minimum, by the end of actually attended treatment.
The difﬁculty of identifying a successful treatment approach for the
patient population as a whole has long led to the conclusion that “one
size does not ﬁt all” (Institute of Medicine Committee on Treatment of
Alcohol, 1990). Instead, the hypothesis has been put forward that
some treatments are possibly more attractive and effective in targeting
certain speciﬁc patient groups than others. It has also been postulated
that the variance in the duration of treatment is too small for signiﬁcant
associations between duration and effect to be found – which consti-
tutes an argument for a larger timescale in studies of duration in therapy
(Buhringer, 2006). Moreover, it is important to note that people who
drop out of treatment are often counted as relapse cases; however,
some dropouts might have rapid trajectories of change and may thus
be considered as successes.
We argue that the complexity of AUD requires both subgrouping of
the population and the measurement of improvements session to ses-
sion – thereby also reporting the actually attended sessions – in order
to study and optimize the appropriate treatment length.
If there are associations between duration and effect of treat-
ment within subgroups, the next question would be: “What, then,
is the optimal treatment duration for this group, and how well
does this match with current recommendations in guidelines?” An
optimal treatment duration is necessary as an argument in the bud-
getary planning and logistics of treatment centers. If the optimal
treatment duration is unknown, ﬂexibility is called for – a ﬂexibility
treatment centers may not always be able to provide, with burden-
some consequences at psychosocial and societal levels (Cuijpers
et al., 2013).
Another aspect concerns how the effect of treatment is assessed. As
discussed by Pearson et al. (Pearson, Kirouac, & Witkiewitz, 2016), the
quantity of alcohol use is not part of the DSM criteria, yet most studies
primarily focus on the quantity of alcohol as ameasure of effect of treat-
ment. The DSM criteria (Association, 2013) are all related to drinking as
such – the quantity is not deﬁned; hence, only a treatment outcome of
full abstinence would be equivalent to no DSM symptoms. As studied
byWilson et al. (2016), whenmeasuring effect of treatment at different
levels of alcohol consumption, there is a risk of too many false positives
and false negatives in levels of psychosocial functioning. Moreover,
studies of the association between drinking levels and consequences
from drinking do not reveal a logical cut-off point in drinking levels
(Pearson, Bravo, Kirouac, & Witkiewitz, 2017). Since many treatment
centers accept controlled drinking as a treatment goal, adding an out-
come reﬂecting psychosocial functioning may be appropriate (Wilson
et al., 2016). A binary classiﬁcation of problematic drinking does not
take into account the level of suffering, the level of blood alcohol content
in the individual, nor the risk of harm – again, one size does not ﬁt all
(Pearson et al., 2016).
4.3. Research assessments and effect
Our ﬁndings support the recommendation for a low frequency of re-
search assessment in studies of AUD (Clifford et al., 2007). Research as-
sessments are a hardly avoidable bias in controlled studies and itmaybe
that research assessments have reduced the ability to detect signiﬁcant
differences between groups in some cases. For example, there has been
speculation about the impact of research assessments in relation to the
Project MATCH (Buhringer, 2006).
Research assessments may function like control visits similar to
those in chronic disease management. Clifford et al. (2007) hypothe-
sized themechanismwasmediated by increased FRAMES (feedback, re-
sponsibility, advice, menu, empathy and self-efﬁcacy), arguing that
there is a therapeutic value to research assessments. In that respect, re-
search assessments may be compared to brief interventions (Clifford &
Maisto, 2000), and our ﬁndings contribute to the discussion about efﬁ-
cacy studies and the implementation of treatments in real-life settings
(Saitz, 2014).
All in all, this emphasizes the clinical relevance of control points for
people suffering from AUD. Importantly, it seems not just to be about a
control point at any given timebut, based on this analysis, the frequency
of control points.
Table 4
Correlations matrix between the variables applied in the review and meta regression of the duration of psychosocial treatment for alcohol use disorder treated in outpatient care.
PDAa PHDb ABSc PHDbasd PDAbase Attended
sessions
Planned
sessions
Attrition
rate
Planned
sessions
per week
Planned
weeks
PDAa 1.00
PHDb −0.83⁎⁎⁎ 1.00
ABSc 0.57⁎⁎⁎ −0.38 1.00
PHDbasd −0.14 0.34⁎⁎ −0.06 1.00
PDAbase 0.29⁎⁎ −0.08 0.54⁎⁎⁎ −0.63⁎⁎⁎ 1.00
Attended sessions 0.16 −0.22 0.58⁎⁎⁎ 0.42⁎⁎ 0.15 1.00
Planned sessions 0.09 −0.38⁎⁎ 0.53⁎⁎⁎ 0.27 0.11 0.86⁎⁎⁎ 1.00
Attrition rate 0.10 0.14 −0.41⁎ 0.15 −0.14 −0.04 −0.47⁎⁎⁎ 1.00
Planned sessions per week −0.01 −0.32⁎ 0.04 −0.19 0.16 0.68⁎⁎⁎ 0.56⁎⁎⁎ −0.02 1.00
Planned weeks 0.18 −0.08 0.47⁎⁎⁎ 0.40⁎⁎ 0.05 0.20 0.53⁎⁎⁎ −0.52⁎⁎⁎ −0.30⁎⁎⁎ 1.00
Follow up time in Weeks −0.04 −0.26⁎ 0.33⁎ −0.02 −0.06 0.25⁎ 0.23⁎ −0.34⁎⁎ −0.09 0.31⁎⁎⁎
Number of research assessments 0.25⁎ −0.36⁎⁎ 0.43⁎⁎⁎ 0.01 −0.03 0.05 0.09 −0.09 −0.20⁎ 0.33⁎⁎⁎
Frequency of research assessments per month 0.34⁎⁎⁎ −0.27⁎ 0.21 −0.08 0.12 −0.17 −0.16 0.19 −0.07 −0.10
Medication in study −0.17 0.38⁎⁎ −0.30⁎ 0.38⁎⁎ −0.24⁎ −0.00 −0.09 0.40⁎⁎⁎ 0.00 −0.14
Abuse of other drugs included 0.28⁎⁎ −0.16 0.57⁎⁎⁎ 0.05 0.44⁎⁎⁎ 0.36⁎⁎⁎ 0.41⁎⁎⁎ −0.32⁎⁎ 0.15 0.36⁎⁎⁎
Missing information of other drugs −0.09 −0.19 −0.11 −0.33⁎ −0.03 −0.14 0.10 −0.10 0.09 −0.00
Major psychiatric disorder included 0.27⁎⁎ −0.18 0.21 −0.14 0.22⁎ 0.00 0.16 −0.20 0.06 0.34⁎⁎⁎
Missing information of major psychiatric disorder in study 0.13 −0.12 0.10 −0.47⁎⁎⁎ 0.26⁎⁎ 0.01 0.09 −0.06 0.14 −0.04
Completers or not 0.19 −0.40⁎⁎ 0.16 −0.37⁎⁎ 0.03 −0.05 −0.04 −0.14 −0.14 0.08
CBT or not 0.08 −0.16 −0.00 −0.10 0.11 0.40⁎⁎⁎ 0.27⁎⁎ −0.23⁎ 0.28⁎⁎ −0.00
a Outcome of percent days abstinent.
b Outcome in percent heavy days of drinking.
c Share of participants abstinent at follow up.
d Baseline percent heavy days of drinking.
e Baseline percent days abstinent.
⁎ p-Value ≤0.05.
⁎⁎ p-Value ≤0.01.
⁎⁎⁎ p-Value ≤0.001.
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4.4. Limitations
There are limitations that may mask possible associations
between duration and effect of treatment in long-term alcohol
use:
Despite well-deﬁned in- and exclusion criteria, the heterogeneity of
study features and population was substantial. By assuming treat-
ment uniformity, the data does not apply to a particular type of in-
tervention. Additionally, we have chosen not to differentiate
betweenmethods in the studies regarding recruitment, quality con-
trol of the therapy, and the blinding of participants and researchers.
We did not have a control group and were, therefore, not able to
control for publication bias. To take the heterogeneity of the popula-
tion into account, some factors reported consistently in the studies
were included in the analysis, but other factors, especially severity
of AUD, could not be included.
Because of heterogeneity in the reporting of psychosocial function-
ing, it was not possible to perform sub-analysis of the associations
between psychosocial functioning and duration of treatment. We
were not able to account for the actually attended weeks, and the
sub-analysis of actually attended sessions and attrition rate left out
one third of the interventions.
The time between screening and baseline as part of the research
study duration could also be important, but this was rarely re-
ported and thus further compromises the accuracy of the data
on duration. Moreover, the duration of the research study was
in some cases longer, with a research assessment point at
52 weeks as one example, but with primary outcome at
26 weeks. This last research assessment was not counted in the
number of research assessments in this analysis, but it may
have affected the primary outcome at 26 weeks if the participant
knew that more assessments lay ahead. Additionally, the choice
to mostly register long-term alcohol use outcomes may mask an
effect of the duration of treatment being evaluated immediately
after treatment.
The possible selection bias in the group of people accepting to take
part in a research study with many research assessments should be
mentioned. To take this into account we investigated the rate of re-
fusal to take part in the study, but the reporting was not consistent.
Finally, with only a few studies that have more than twenty-six
weeks of planned treatment, this study cannot draw conclusions re-
garding more extended treatment.
4.5. Strengths
Our analysis is based on a substantial sample size of people suffering
from alcohol use disorders withmean descriptive factors comparable to
the populations treated in many real-life alcoholic outpatient care cen-
ters. Asmany variables as possible were taken into account in themeta-
regression, showing diverse effects related to subgroups. This study vi-
sualizes the complexity of recommending a speciﬁc duration of psycho-
social treatment for such a diverse group as people with AUD.
5. Perspective
Our review raises methodological considerations for future studies,
notably the need formore consistent and detailed reporting of the char-
acteristics of the participants, rate of refusal to participate, duration of
the study in several aspects (actually attended weeks and sessions,
and duration from ﬁrst approach to participants until baseline), as
well as description and quality assessment of all interventions including
the control condition. We recommend that data be collected at an indi-
vidual level and session by session to enable analysis for optimal indi-
vidualized treatment duration and effect of treatment. If not reported,
we recommend publicly sharing data at the individual level to facilitate
secondary analysis. For a more multifaceted aspect of treatment effects,
there is a need for consensus on how to report psychosocial functioning
and to include psychosocial functioning as an outcome presented with
Follow
up time
in weeks
Number of
research
assessments
Frequency of
research assessments
per month
Medication
in study
Abuse of
other drugs
included
Missing
information
of other drugs
Major psychiatric
disorder
included
Missing information
of major psychiatric
disorder in study
Completers
or not
CBT or
not
1.00
0.37⁎⁎⁎ 1.00
−0.42⁎⁎⁎ 0.39⁎⁎⁎ 1.00
−0.24⁎⁎ −0.09 0.17 1.00
0.25⁎⁎ 0.15 0.13 −0.33⁎⁎⁎ 1.00
−0.01 0.00 −0.12 −0.26⁎⁎ −0.23⁎⁎ 1.00
0.08 0.29⁎⁎⁎ 0.06 −0.13 0.40⁎⁎⁎ −0.09 1.00
−0.02 −0.19⁎ −0.15 −0.24⁎⁎ 0.10 0.55⁎⁎⁎ −0.09 1.00
0.26⁎⁎ 0.19⁎ −0.18⁎ −0.43⁎⁎⁎ 0.04 0.13 0.16 0.20⁎ 1.00
−0.05 −0.09 −0.03 −0.08 −0.00 −0.01 0.20⁎ 0.02 0.15 1.00
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effect sizes. Future research should target treatment of subgroups of pa-
tients with alcohol use disorder, thereby reducing the heterogeneity of
groups compared. Low frequency of research assessments is encour-
aged if we wish to assess the impact of the treatment as such. Finally,
randomized controlled studies of different durations of the same inter-
vention would be ideal.
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